Home Cart 0 Sign in  

[ CAS No. 1010814-94-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1010814-94-4
Chemical Structure| 1010814-94-4
Structure of 1010814-94-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 1010814-94-4 ]

Related Doc. of [ 1010814-94-4 ]

Alternatived Products of [ 1010814-94-4 ]
Product Citations

Product Details of [ 1010814-94-4 ]

CAS No. :1010814-94-4 MDL No. :MFCD11111810
Formula : C16H27NO5 Boiling Point : No data available
Linear Structure Formula :- InChI Key :ALIVCUSTZCGWKQ-UHFFFAOYSA-N
M.W : 313.39 Pubchem ID :49759529
Synonyms :

Calculated chemistry of [ 1010814-94-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.81
Num. rotatable bonds : 7
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 86.96
TPSA : 72.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.21 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.49
Log Po/w (XLOGP3) : 1.41
Log Po/w (WLOGP) : 2.16
Log Po/w (MLOGP) : 1.44
Log Po/w (SILICOS-IT) : 2.03
Consensus Log Po/w : 2.11

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.21
Solubility : 1.94 mg/ml ; 0.00618 mol/l
Class : Soluble
Log S (Ali) : -2.55
Solubility : 0.893 mg/ml ; 0.00285 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.45
Solubility : 1.11 mg/ml ; 0.00355 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.41

Safety of [ 1010814-94-4 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1010814-94-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1010814-94-4 ]

[ 1010814-94-4 ] Synthesis Path-Downstream   1~6

  • 1
  • [ 5292-43-3 ]
  • [ 1010814-94-4 ]
YieldReaction ConditionsOperation in experiment
50.6% To a solution of diisopropylamine (13.5 ml, 96 mmol) in THF (300 ml) at -78C was added dropwise n-BuLi (2.5M in Hex, 32 ml). The mixture was warmed to -100C and re-cooled to -78C. A solution of 4-oxo-piperidine-l-carboxylic acid tert-butyl ester (10 g, 50 mmol) in THF (50 ml) was then added dropwise and the mixture stirred at -78C for another 15 min. A solution of tert-butyl bromoacetate (12.6 ml, 85 mmol) in THF (30 ml) and HMPT (5 ml) was then added dropwise and the mixture stirred at -78C for 4 h and then gradually warmed to rt. The mixture was taken up in sat. aq. NH4Cl and extracted with EA. The yield after work up and chromatography (eluent Hex/EA 4:1) was 7.6 g (50.6%; yellowish oil).1H NMR (CDCl3) delta: 4.40-4.20 (m, 2H); 3.25-3.15 (m, IH); 3.00-2.80 (m, 2H); 2.70-2.40 (m, 3H); 2.30-2.10 (m, IH); 1.51 (s, 9H), 1.46 (s, 9H).
  • 2
  • [ 1010814-94-4 ]
  • [ 1010814-95-5 ]
YieldReaction ConditionsOperation in experiment
60% Methyltriphenylphosphonium bromide (8.5 g, 23.9 mmol) was suspended in THF (23 ml) and treated with KOtBu (2.7 g, 23.9 mmol). The resulting yellow suspension was stirred at rt for 1 h. A solution of the intermediate 7.i (3.0 g, 9.6 mmol) in THF was added dropwise and the mixture was stirred at rt for 2 h, taken up in water and diluted with ether. The yield after work up and chromatography (Hex:EA 9:1) was 1.8 g (60%; colourless oil). 1H NMR (CDCl3) delta: 4.80 (s, IH); 4.75 (s, IH); 4.60-4.20 (m, 4H); 2.80-2.60 (m, IH); 2.50-2.25 (m, 3H); 2.25-2.10 (m, IH); 1.48 (s, 9H); 1.46 (s, 9H).
  • 3
  • [ 5292-43-3 ]
  • [ 79099-07-3 ]
  • [ 1010814-94-4 ]
YieldReaction ConditionsOperation in experiment
To a solution of diisopropylamine (7.41 g, 73.2 mmol) in dry tetrahydrofuran (150 mL) was added n-BuLi (2.5 M, 16 mL) dropwise at -70 C under nitrogen. The resultant mixture was warmed to -10 C and stirred for 30 min. The mixture was cooled to -70 C, and a solution of tert-butyl 4-oxopiperidine-1-carboxylate (5.00 g, 25.1 mmol) in dry tetrahydrofuran (20.0 mL) was added dropwise and stirred for 30 min. Then, a solution of tert-butyl 2-bromoacetate (4.89 g, 25.1 mmol) in tetrahydrofuran (20.0 mL) was added dropwise, followed by hexamethylphosphoramide (HMPA) (1.80 g, 11.0 mmol). On completion, to the mixture was added water (10 mL), and the solution was extracted with ethyl acetate (3 x 50 mL). The combined ethyl acetate phase was dried over sodium sulfate and concentrated in vacuo. The residue was purified by column chromatography (petroleum ether:ethyl acetate = 0:1 to 100:1) to give the title compound. 1H NMR (300 MHz, CDCl3) delta = 4.22 - 4.03 (m, 1H), 3.65 (t, J = 6.0 Hz, 2H), 2.83 (s, 1H), 2.57 - 2.33 (m, 4H), 2.32 - 2.06 (m, 1H), 1.43 (s, 9H), 1.38 (s, 9H).
  • 4
  • [ 1010814-94-4 ]
  • C26H35Cl2N3O5 [ No CAS ]
  • 5
  • [ 1010814-94-4 ]
  • (±)-tert-butyl 4-amino-3-(2-(tert-butoxy)-2-oxoethyl)piperidine-1-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With ammonium acetate; sodium cyanoborohydride; In tetrahydrofuran; at 20℃; for 16h;Molecular sieve; To a mixture of (±)-tert-butyl 3-(2-tert-butoxy-2-oxo-ethyl)-4-oxo-piperidine-1- carboxylate (2.00 g, 6.38 mmol) in tetrahydrofuran (20.0 mL) was added ammonium acetate (1.48 g, 19.1 mmol), followed by 4A MS (500 mg), and sodium cyanotrihydroborate (1.20 g, 19.1 mmol) in one portion at 20 C. The mixture was stirred at 20 C for 16 hrs. On completion, to the mixture was added water (30 mL) and the solution was extracted with dichloromethane (3 x 30 mL). The combined dichloromethane phase was dried over sodium sulfate and concentrated in vacuo. The crude product was purified by column chromatography (petroleum ether:ethyl acetate = 10:1 to dichloromethane:methanol = 20:1) to give the title compound (crude).1H NMR (400 MHz, DMSO-d6) delta = 3.90 - 3.72 (m, 2H), 3.41 - 3.31 (m, 1H), 3.08 - 2.74 (m, 3H), 2.37 - 2.24 (m, 1H), 1.87 - 1.84 (m, 1H), 1.63 - 1.39 (m, 19H).
  • 6
  • [ 1010814-94-4 ]
  • [ 1010814-96-6 ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 1010814-94-4 ]

Amides

Chemical Structure| 877173-80-3

[ 877173-80-3 ]

tert-Butyl 3-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylate

Similarity: 0.97

Chemical Structure| 891494-65-8

[ 891494-65-8 ]

tert-Butyl 3-(3-methoxy-3-oxopropanoyl)-piperidine-1-carboxylate

Similarity: 0.95

Chemical Structure| 98977-34-5

[ 98977-34-5 ]

1-tert-Butyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate

Similarity: 0.94

Chemical Structure| 479630-08-5

[ 479630-08-5 ]

1-Boc-4-(2-Ethoxycarbonyl-acetyl)piperidine

Similarity: 0.93

Chemical Structure| 194726-40-4

[ 194726-40-4 ]

(R)-1-tert-Butyl 3-ethyl piperidine-1,3-dicarboxylate

Similarity: 0.93

Esters

Chemical Structure| 877173-80-3

[ 877173-80-3 ]

tert-Butyl 3-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylate

Similarity: 0.97

Chemical Structure| 891494-65-8

[ 891494-65-8 ]

tert-Butyl 3-(3-methoxy-3-oxopropanoyl)-piperidine-1-carboxylate

Similarity: 0.95

Chemical Structure| 98977-34-5

[ 98977-34-5 ]

1-tert-Butyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate

Similarity: 0.94

Chemical Structure| 479630-08-5

[ 479630-08-5 ]

1-Boc-4-(2-Ethoxycarbonyl-acetyl)piperidine

Similarity: 0.93

Chemical Structure| 194726-40-4

[ 194726-40-4 ]

(R)-1-tert-Butyl 3-ethyl piperidine-1,3-dicarboxylate

Similarity: 0.93

Ketones

Chemical Structure| 877173-80-3

[ 877173-80-3 ]

tert-Butyl 3-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylate

Similarity: 0.97

Chemical Structure| 891494-65-8

[ 891494-65-8 ]

tert-Butyl 3-(3-methoxy-3-oxopropanoyl)-piperidine-1-carboxylate

Similarity: 0.95

Chemical Structure| 98977-34-5

[ 98977-34-5 ]

1-tert-Butyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate

Similarity: 0.94

Chemical Structure| 479630-08-5

[ 479630-08-5 ]

1-Boc-4-(2-Ethoxycarbonyl-acetyl)piperidine

Similarity: 0.93

Chemical Structure| 193274-53-2

[ 193274-53-2 ]

Methyl 1-Boc-3-methyl-4-oxo-piperidine-3-carboxylate

Similarity: 0.92

Related Parent Nucleus of
[ 1010814-94-4 ]

Aliphatic Heterocycles

Chemical Structure| 877173-80-3

[ 877173-80-3 ]

tert-Butyl 3-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylate

Similarity: 0.97

Chemical Structure| 891494-65-8

[ 891494-65-8 ]

tert-Butyl 3-(3-methoxy-3-oxopropanoyl)-piperidine-1-carboxylate

Similarity: 0.95

Chemical Structure| 98977-34-5

[ 98977-34-5 ]

1-tert-Butyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate

Similarity: 0.94

Chemical Structure| 479630-08-5

[ 479630-08-5 ]

1-Boc-4-(2-Ethoxycarbonyl-acetyl)piperidine

Similarity: 0.93

Chemical Structure| 194726-40-4

[ 194726-40-4 ]

(R)-1-tert-Butyl 3-ethyl piperidine-1,3-dicarboxylate

Similarity: 0.93

Piperidines

Chemical Structure| 877173-80-3

[ 877173-80-3 ]

tert-Butyl 3-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylate

Similarity: 0.97

Chemical Structure| 891494-65-8

[ 891494-65-8 ]

tert-Butyl 3-(3-methoxy-3-oxopropanoyl)-piperidine-1-carboxylate

Similarity: 0.95

Chemical Structure| 98977-34-5

[ 98977-34-5 ]

1-tert-Butyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate

Similarity: 0.94

Chemical Structure| 479630-08-5

[ 479630-08-5 ]

1-Boc-4-(2-Ethoxycarbonyl-acetyl)piperidine

Similarity: 0.93

Chemical Structure| 194726-40-4

[ 194726-40-4 ]

(R)-1-tert-Butyl 3-ethyl piperidine-1,3-dicarboxylate

Similarity: 0.93

; ;